Brain stem cell implant trial aims to ease Parkinson's symptoms

NCT ID NCT07106021

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 33 times

Summary

This early-stage trial tests whether implanting special dopamine-producing stem cells into the brain is safe for people with Parkinson's disease. Twelve participants aged 45 to 75 will undergo a surgical procedure to receive the cells. The main goal is to check for side effects, while also monitoring changes in movement and brain function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PARKINSON´S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Keck Medical Center of University of Southern California

    RECRUITING

    Los Angeles, California, 90033, United States

  • The Ohio State University Wexner Medical Center

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Arizona

    RECRUITING

    Tucson, Arizona, 85721, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.